Pharmathen has licensed out its in house developments to all the major EU generic companies as well as the leading national generic businesses. We collaborate with more than 200 companies within the EU, Canada, Australia and recently the U.S.. Currently we are handling over 3000 Marketing Applications and we expect this number to continuously increase in the years ahead as our development portfolio increases.

We are always interested in new opportunities.
Below you see a complete list with available products for licensing out.